HomeGreater Than Icon
StocksGreater Than Icon
Unjha Formulations Ltd
company logo

Unjha Formulations Ltd

UNJHAFORMUL Share Price

BSE:531762

₹27.55

-0.45 (-1.61%)

As on August 14, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

28

27

2062

0.01

10

Fundamentals

₹12.34Cr

26.24

3.21

0

1.05

0%

8.58

About

Unjha Formulations Limited was established in June, 1987 as a Partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. The Company is a pioneer in Isabgol (Psyllium) Formulation. The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The company's products are classified under two divisions -- human consumption and veterinary products. Company launched four new products viz.Bericof, Protobal-NT, Formentin Tablets and Nalizole in the year 1997-98. The Company commenced its commercial production and was successfully expanding its customer base throughout the Country including U.P. Territory. Company also interested on development of Export Markets for Ferrous Sulphate, Albendazole Bolus and Iron Folic Tablets to supplement the present law domestic demand situation and achieved export turnover of Rs.0.98 during the year 1997-98. During 2002-03, the Company made manufacturing agreement with Nicholas Piramal India Limited for sale of Isabgol Husk based product TYBOGEL' and Morepen Laboratories Ltd. for sale of Dr.Mopren Sat Isabgol. It had manufacturing agreement with Karnataka Antibiotics & Pharmaceuticals Limited for sale of Isabgol Husk based products and other veterinary products on Loan Licence basis. In 2026, the Company made manufacturing agreement with Reckit Benckiser India Ltd., for sales of Isabgol Husk based product 'Fybogel', Abbot HealthcatePvt Ltd., for sales of FABOLITE' Karnataka Antibiotics & Pharmaceuticals Ltd for sale of 'Husky',RadiantNutracetical Bangladesh for exports, Rhine Biogenics Pvt. Ltd for sale of Trugol SF Powder' Nutragenix Healthcare Pvt Ltd. for sale of Fibapure Group of product and Appolo Pharmacy for sale of Sat-Isabgol etc. Company signed further manufacturing agreement with Karnataka Antibiotics & Pharmaceuticals Limited for sale of Isabgol Husk based product. It focused on development of Export Markets, for Albendazole Bolus, Fibron SF Powder and Fibermate (Isabgol based formulations) to supplement the present low domestic demand situation.

Krutiben M Patel

1994

NameDesignation
Jashodaben S PatelChairperson
Esham. PatelExecutive Director
Krutiben M PatelManaging Director
Hasmukh C ChavdaIndependent Non Exe. Director
Jitendra P. LimbachiyaIndependent Non Exe. Director
Mustufa Najmuddin JodhpurwalaIndependent Non Exe. Director
Khushboo N PatelCompany Secretary

Unjha Formulations Ltd FAQs

How do I Buy Unjha Formulations Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Unjha Formulations Ltd shares in BlinkX.

What is the Share Price of Unjha Formulations Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Unjha Formulations Ltd's share price is ₹27.55 as of 2026-08-16.

What is the PE ratio of Unjha Formulations Ltd?

close

Unjha Formulations Ltd's P/E ratio is 26.24 times as of 2026-08-16.

What is the PB ratio of Unjha Formulations Ltd?

close

Unjha Formulations Ltd's most recent financial reports indicate a price-to-book ratio of 3.21, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Unjha Formulations Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Unjha Formulations Ltd's market capitalization is ₹12.34 Cr as on 2026-08-16.

What is the ROE of Unjha Formulations Ltd?

close

The current financial records of Unjha Formulations Ltd show a 14.97% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Unjha Formulations Ltd?

close

According to Unjha Formulations Ltd's most recent financial filings, the company has a total asset value of ₹4.22, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Unjha Formulations Ltd?

close

The 52-week high/low price of a Unjha Formulations Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Unjha Formulations Ltd's 52-week high and low as of 2026-08-16 are ₹29.5 and ₹17.52, respectively.